Skip to content
Master Lecture on Kidney and Bladder Cancer
Master Lecture on Prostate Cancer: Targeted Therapy PSMA and More
Master Lecture on Ovarian, Fallopian Tube and Uterine Carcinomas
Master Lecture on Triple Negative Breast Cancer
Master Lecture on Endocrine Therapy in Early/Advanced Breast Cancer
Master Lecture on HER-2 in Breast Cancer
Efforts to Overcome Resistance to First Line Immunotherapy
Immunotherapy in Metastatic NSCLC: How to Choose Initial Therapy and What’s New?
Antibody Drug Conjugates in NSCLC
KRAS and EGFR Exon 20 Insertion
EGFR and Resistant Mechanisms
Immunotherapy in Kidney and Bladder Carcinomas
Targeted Therapy in Sarcomas Beyond GIST
Targeted Therapy for Ovarian and Uterine Tumors
Brain Tumors: Is Time for Personalized Medicine?
Developing Targeted Therapy for Genito-Urinary Malignancies
Cholangiocarcinoma, Hepatoma and Pancreas: What’s New
Novel Advances in Colorectal Cancer Other Than Immunotherapy
Developments in Esophageal and Gastric Tumors
Immunotherapy and Exciting Updates in Advanced Prostate Cancer
Immunotherapy for Gynecology-Oncology Malignancies: Is There Still Time for Progress?
Establishing Immunotherapy Management in Gastrointestinal Cancers
Immunotherapy and Targeted Agents in Head/Neck Cancer
